 Daily Rosetta |
HBM Bioventures exits Asthmatx for $193m
AltAssets Swiss venture capital firm HBM Bioventures has sold asthma medical device company Asthmatx to medical technology company Boston Scientific for $193.5m, … Boston Scientific to Buy Asthmatx for $193.5 Million Gaining Asthma Device Boston Sci to buy Asthmatx for more than $193 mln Boston Scientific Acquiring Maker of Non-Drug Asthma Treatment |
View full post on asthma – Google News